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Abstract: Smartwatches like the Apple Watch have been on the rise worldwide and their 
use is gaining popularity in developing countries. Their ability to detect dysrhythmias is well 
documented. Present practice discourages the use of these devices as a diagnostic tool. 
Nevertheless, atypical findings from these devices should be clinically investigated. This 
case demonstrates an eventual diagnosis of supraventricular tachycardia (SVT) based on an 
Apple watch alert which was subsequently confirmed by electrophysiological evaluation. 
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Introduction
Global sales of wearable smartwatches have grown at an annual rate beyond 20%, 
with approximately half a billion active users in 2020 which is expected to double 
by 2022.1 The incorporation of photoplethysmographic (PPG) sensors into smart-
watches has enhanced extensive community-based heart rate monitoring. The latest 
version of smartwatches incorporate the PPG sensor that can identify pulse rate and 
regularity offering precise results directly to the user. Despite having a paucity of 
scientific evidence to support the use of these devices to detect either symptomatic 
or malignant arrhythmias. There are numerous anecdotal reports of patients saved 
by their smartwatches which were able to detect and warn the user of an 
arrhythmia.1 We hereby present a case of a 42-year-old African male who was 
alerted to a possible arrhythmia by his smart watch and was subsequently diagnosed 
to have supraventricular tachycardia (SVT).
Case Report
A 42-year-old male with well-controlled hypertension on once-daily Losartan 
50 mg presented with acute chest discomfort associated with palpitations and 
lightheadedness. He was at home watching television when these symptoms started 
acutely and continued for almost 10 minutes. In addition, his Apple Watch (Apple 
Watch Series 4) recorded a high resting heart rate of 210 beats/min (Figure 1). 
Alarmed at the elevated heart rate, he hurried to the emergency department. On 
examination, the patient was conscious, awake and oriented with warm peripheral 
extremities. Initial vitals at the emergency department revealed tachycardia of 184 
beats/minute, blood pressure of 120/80 mmHg and respiratory rate of 16 cycles 
per minute; his oxygen saturation was 99% on room air. Systemic examination was 
unremarkable. A 12 lead electrocardiogram (ECG) was performed (Figure 2) and 
revealed supraventricular tachycardia at the rate of 184 b/min. The patient was 
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given intravenous Adenosine 6 mg and then two additional 
doses of 12 mg via cubital peripheral line but failed to 
revert to a normal sinus rhythm. At this point, he devel-
oped hypotension and was quickly electrically cardio-
verted (synchronized DC 50 Joules) and successfully 
reverted to normal sinus rhythm as seen in the repeat 
ECG below (Figure 3). Subsequent workup with 
a complete blood count, thyroid panel, repeated cardiac 
enzymes, Troponin I, electrolytes, renal functions were all 
normal. 2D echocardiogram revealed normal left ventricu-
lar systolic (ejection fraction 60%) and diastolic functions 
with normal-sized chambers. Coronary angiography 
demonstrated no evidence of epicardial coronary artery 
disease. The patient was discharged on daily Nebivolol 
5 mg, Atorvastatin 20 mg and continued his daily 
Losartan 50 mg with a plan of electrophysiological studies 
(EPS) to establish the possible cause of the symptomatic 
supraventricular tachycardia (SVT). With no EPS studies 
available in our country, he subsequently flew to India 
after four weeks and underwent an electrophysiology eva-
luation which revealed inducible tachycardia on pacing 
protocols. In addition, electrophysiological mapping 
showed reproducible SVT, which was orthodromic atrio-
ventricular reentrant tachycardia (oAVRT) utilizing para-
hisian accessory pathway as retrograde conduction. 
A ten second ablation was done on the non-coronary 
Figure 1 Apple watch record of the patient’s heart rate.
Figure 2 EKG showing supraventricular tachycardia.
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sinus (NCS), which was considered the best option but had 
no effect on the tachycardia. A test ablation was consid-
ered on the parahisian pathway but was deemed to be 
associated with too high of a risk for permanent pacing, 
which the patient declined. The patient was discharged on 
medical management with the option of cryoablation for 
the failure of medical therapy. A 6 and 12 month’s follow- 
up has been uneventful.
Discussion
To our knowledge, this is the first published case report in 
Sub-Saharan Africa whereby the Apple Watch was an inte-
gral part of the diagnostic process. Many patients who 
present to health care facilities reporting awareness of 
heartbeat require extensive workup: including ambulatory 
rhythm monitoring, noninvasive imaging, pharmacotherapy 
and invasive electrophysiological (EP) procedures to reach 
diagnosis.2 Literature from the African context shows that 
even though patients may present for care, most facilities 
are ill-equipped and lack necessary diagnostic capabilities 
both in human resources and equipment.3 This advance-
ment in technology has shed light on the medical world and 
can therefore be considered a significant adjunct to 
conventional rhythm monitoring. Nevertheless, it is 
a dangerous practice to solely depend on it to detect heart 
conduction abnormalities. This technology has led to an 
extensive assessment of smartwatches to identify atrial 
fibrillation.4 The findings of this study were clinically rele-
vant since 34% of those who received an irregular pulse 
notification were subsequently diagnosed to have atrial 
fibrillation on ECG patch readings.4 Additionally, case ser-
ies have also been published whereby two patients’ actual 
watch-based 3-lead ECG tracings corresponded to the tradi-
tional ECGs demonstrating ST-elevation myocardial infarc-
tion (STEMI), confirming the potential ability of this device 
also to detect myocardial ischemia.5 Only one validation 
study has assessed the accuracy of the wrist-worn wearable 
device on 51 patients who were scheduled for EPS due to 
a history of paroxysmal supraventricular tachyarrhythmia 
(SVT) or paroxysmal palpitations. This study showed an 
acceptable accuracy of these devices to measure baseline 
and induced SVT.6
Conclusion
This case highlights the importance of wearable gadgets to 
detect asymptomatic arrhythmia. Atrial fibrillation is 
Figure 3 EKG showing normal sinus rhythm following electrical cardioversion.
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considered most prevalent among hypertensive patients in 
Tanzania.7 The use of such devices will therefore aid in 
seeking prompt care and management. However, false- 
positive notifications can trigger anxiety and increase 
unnecessary hospital visits. The American and European 
heart rhythm society has not approved this technology as 
a diagnostic tool8 rather a nidus for the community to seek 
medical advice when notified.
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